Latest filing published 10 Mar 2026 for National Healthcare CORP, €152k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +75.6%Entry US$55.72 · Close at T+365 US$97.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James Paul Abernathy: trading record in brief
This profile gathers the share dealings of James Paul Abernathy across 2 companies, led by National Healthcare Corp and National Health Realty Inc. We count 111 filings; the first trade dates from 6 January 2006 and the latest from 9 March 2026.
The open-market side counts 2 purchases for €134k alongside 59 sales for €2.0M. On balance, insiders were net sellers of €1.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 15 share grants and 34 option exercises.
On 10 March 2026 came the latest disclosure, an option exercise for €152k in National Healthcare Corp. The most recent open-market purchase was published on 27 February 2023, 1,351 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Paul Abernathy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,140 shares@ US$55.750.0050% mcap7.5% of flowShares of Common StockSEC:0001437749-26-007533:0
- 3,732 shares@ US$139.015.8% of flowShares of Common StockSEC:0001437749-26-001443:1
- 7,500 shares@ US$69.8222.2% of flowShares of Common StockSEC:0001437749-26-001443:0
- 2,639 shares@ US$108.823.2% of flowShares of Common StockSEC:0001437749-25-027145:1
- 4,010 shares@ US$71.6412.1% of flowShares of Common StockSEC:0001437749-25-027145:0
- 1,745 shares@ US$71.645.9% of flowShares of Common StockSEC:0001437749-25-004609:0
- 1,605 shares@ US$126.99839.1% of flowShares of Common StockSEC:0001437749-24-027024:0
- 1,745 shares@ US$71.645.7% of flowShares of Common StockSEC:0001437749-24-005083:0
- 4,912 shares@ US$93.505.4% of flowShares of Commmon StockSEC:0001437749-24-000878:1
- 7,500 shares@ US$64.645.8% of flowShares of Common StockSEC:0001437749-24-000878:2
- 5,185 shares@ US$93.505.8% of flowShares of Common StockSEC:0001437749-24-000878:3
- 5,895 shares@ US$77.9220.8% of flowShares of Common StockSEC:0001437749-24-000878:0
- 1,550 shares@ US$68.224.8% of flowShares of Common StockSEC:0001437749-23-024777:0
- 2,176 shares@ US$57.455.8% of flowShares of Common StockSEC:0001437749-23-004762:0Canonical exit: 24 May 2023 (T+90)
- 2,020 shares@ US$61.905.9% of flowShares of Common StockSEC:0001437749-22-012335:0
- 2,020 shares@ US$61.901.8% of flowShares of Common StockSEC:0001437749-21-004977:0
- 1,605 shares@ US$77.924.0% of flowShares of Common StockSEC:0001437749-20-003501:0
- 5,508 shares@ US$62.788.7% of flowShares of Common StockSEC:0001437749-20-000806:0
- 3,958 shares@ US$87.358.7% of flowShares of Common StockSEC:0001437749-20-000806:1
- 1,714 shares@ US$84.783.6% of flowShares of Common StockSEC:0001437749-19-016706:0
- 919 shares@ US$79.501.5% of flowShares of Common StockSEC:0001437749-19-011675:0
- 1,714 shares@ US$72.942.5% of flowShares of Common StockSEC:0001437749-19-004616:0
- 3,418 shares@ US$61.254.1% of flowShares of Common StockSEC:0001437749-19-002638:0
- 2,499 shares@ US$83.754.1% of flowShares of Common StockSEC:0001437749-19-002638:1
- 1,877 shares@ US$80.002.8% of flowShares of Common StockSEC:0001437749-18-021093:0
25 of 108 declarations
